Shengying LIN

Dr. Shengying LIN

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 June 2022 in Molecules
Verified
Journal Article
Open access
PDF file
SLShengying LIN
Shengying LIN
XWXiaoyang WANG
Xiaoyang WANG
RTRoy Wai-Lun Tang Roy Wai-Lun Tang
Roy Wai-Lun Tang Roy Wai-Lun Tang
HLHung Chun Lee
Hung Chun Lee
HCHo Hin Chan
Ho Hin Chan
Karl TsimKarl Tsim
Karl Tsim
COVID-19, resulting from infection by the SARS-CoV-2 virus, caused a contagious pandemic. Even with the current vaccines, there is still an urgent need to develop effective pharmacological treatments against this deadly disease. Here, we show that the water and ethanol extracts of the root and rhizome of Polygonum cuspidatum (Polygoni Cuspidati Rhizoma et Radix), a common Chinese herbal medicine, blocked the entry of wild-type and the omicron variant of the SARS-CoV-2 pseudotyped virus into fibroblasts or zebrafish larvae, with IC50 values ranging from 0.015 to 0.04 mg/mL. The extracts were shown to inhibit various aspects of the pseudovirus entry, including the interaction between the spike protein (S-protein) and the angiotensin-converting enzyme II (ACE2) receptor, and the 3CL protease activity. Out of the chemical compounds tested in this report, gallic acid, a phytochemical in P. cuspidatum, was shown to have a significant anti-viral effect. Therefore, this might be responsible, at least in part, for the anti-viral efficacy of the herbal extract. Together, our data suggest that the extracts of P. cuspidatum inhibit the entry of wild-type and the omicron variant of SARS-CoV-2, and so they could be considered as potent treatments against COVID-19.

6 December 2022 in Aquaculture
Verified
Journal Article
Closed access
YXYi-Teng Xia
Yi-Teng Xia
ECEdwin Hok-Chi Cheng
Edwin Hok-Chi Cheng
HWHuai-You Wang
Huai-You Wang
LZLynn Hoi-Lam Zhang
Lynn Hoi-Lam Zhang
SLShengying LIN
Shengying LIN
Karl TsimKarl Tsim
Karl Tsim

8 January 2022 in Molecules
Verified
Journal Article
Open access
PDF file
GYGary Ka-Wing Yuen
Gary Ka-Wing Yuen
BHBryan Siu-Yin Ho
Bryan Siu-Yin Ho
SLShengying LIN
Shengying LIN
TDTina Tingxia Dong
Tina Tingxia Dong
Karl TsimKarl Tsim
Karl Tsim
To search hair growth-promoting herbal extract, a screening platform of having HEK293T fibroblast being transfected with pTOPFLASH DNA construct was developed over a thousand of herbal extracts and phytochemicals were screened. One of the hits was ethanolic extract of Rhizoma Belamcandae, the rhizome of Belamcanda chinensis (L.) DC. Tectoridin, an isoflavone from Rhizoma Belamcandae, was shown to be responsible for this activation of promoter construct, inducing the transcription of pTOPFLASH in the transfected fibroblasts in a dose-dependent manner. The blockage by DKK-1 suggested the action of tectoridin could be mediated by the Wnt receptor. The hair growth-promoting effects of tectoridin were illustrated in human follicular dermal papilla cells and mouse vibrissae organ cultures. In tectoridin-treated dermal papilla cultures, an activation of Wnt signaling was demonstrated by various indicative markers, including TCF/LEF1 transcriptional activity, nuclear translocation of β-catenin, expressions level of mRNAs encoding axin-related protein, (AXIN2), β-catenin, lymphoid enhancer-binding factor-1 (LEF-1), insulin-like growth factor 1 (IGF-1) and alkaline phosphatase (ALP). In addition, an increase of hair shaft elongation was observed in cultured mouse vibrissae upon the treatment of tectoridin. Tectoridin, as well as the herbal extract of Rhizoma Belamcandae, possesses hair promoting activity, which deserves further development.

Verified
Journal Article
Open access
PDF file
SLShengying LIN
Shengying LIN
XWXiaoyang WANG
Xiaoyang WANG
HGHongsheng Guo
Hongsheng Guo
NDNiyu Dai
Niyu Dai
RTRoy Wai-Lun Tang Roy Wai-Lun Tang
Roy Wai-Lun Tang Roy Wai-Lun Tang
Karl TsimKarl Tsim
Karl Tsim
COVID-19, derived from SARS-CoV-2, has resulted in millions of deaths and caused unprecedented socioeconomic damage since its outbreak in 2019. Although the vaccines developed against SARS-CoV-2 provide some protection, they have unexpected side effects in some people. Furthermore, new viral mutations reduce the effectiveness of the current vaccines. Thus, there is still an urgent need to develop potent non-vaccine therapeutics against this infectious disease. We recently established a series of detecting platforms to screen a large library of Chinese medicinal herbs and phytochemicals. Here, we reveal that the ethanolic extract of Evodiae Fructus and one of its components, rutaecarpine, showed promising potency in inhibiting the activity of 3C-like (3CL) protease, blocking the entry of the pseudo-typed SARS-CoV-2 (including wild-type and omicron) into cultured cells. In addition, inflammatory responses induced by pseudo-typed SARS-CoV-2 were markedly reduced by Evodiae Fructus extract and rutaecarpine. Together our data indicate that the herbal extract of Evodiae Fructus and rutaecarpine are potent anti-SARS-CoV-2 agents, which might be considered as a treatment against COVID-19 in clinical applications.